Abstract
Endomyocardial Fibrosis (EMF) is a cardiomyopathy restrictive that in period of training moderated or advanced presents functional classifications II and III of the New York Heart Association equivalent to the cardiac deficiency (IC), was first described by Davies in the Uganda in 1948, is of bigger incidence in tropical regions and subtropicais of the world, and is characterized by the d…